598 studies found for:    "Diabetic Angiopathies"
Show Display Options
Rank Status Study
21 Recruiting CSTC1 for Diabetic Foot Ulcers Phase II Study
Conditions: Diabetic Foot Ulcer;   Diabetes Mellitus;   Wounds
Interventions: Drug: CSTC1;   Drug: CSTC1 Matched vehicle
22 Completed Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
Condition: Proliferative Diabetic Retinopathy
Intervention:
23 Completed Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
Conditions: Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Drug: bevacizumab
24 Completed Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Conditions: Diabetic Retinopathy;   Macular Oedema
Intervention: Drug: Ranibizumab
25 Recruiting Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water
Condition: Soft Tissue Infections
Interventions: Procedure: chlorhexidine gluconate;   Other: deionized water
26 Completed Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
Conditions: Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Drug: MS-R001 (rapamycin)
27 Active, not recruiting Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: Esmolol hydrochloride;   Drug: Placebo gel
28 Recruiting Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes
Conditions: Diabetes;   Diabetic Retinopathy
Interventions: Drug: Fenofibrate 145 mg;   Drug: Placebo
29 Recruiting Effect of Local Application of Boron on Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: boron gel;   Drug: Placebo
30 Completed Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy
Condition: Diabetic Macular Edema
Interventions: Drug: 2304 Eye Drops High Dose;   Drug: 2304 Eye Drops Low Dose;   Drug: Placebo Eye Drops
31 Completed Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
Conditions: Diabetic Retinopathy;   Macular Edema
Interventions: Drug: Ketorolac;   Drug: Nepafenac;   Drug: Polietilenglicol 400, propilenglicol
32 Terminated Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride;   Drug: Oral placebo capsules
33 Terminated A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX
Conditions: Foot Ulcer;   Diabetic Foot;   Skin Ulcer;   Diabetic Neuropathies
Intervention: Drug: Becaplermin
34 Recruiting Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot
Conditions: Diabetic Foot;   Lower Limb Ischemia
Intervention: Biological: Mesenchymal stem cells
35 Recruiting Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
Conditions: Peripheral Arterial Disease;   Diabetic Foot
Interventions: Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
36 Active, not recruiting Nepafenac Once Daily for Macular Edema - Study 2
Conditions: Non-Proliferative Diabetic Retinopathy;   Cataract
Interventions: Drug: Nepafenac Ophthalmic Suspension, 0.3%;   Other: Nepafenac Vehicle;   Drug: Prednisolone acetate ophthalmic suspension
37 Terminated
Has Results
Diabetic Foot Infection Antibiotic Study
Condition: Diabetic Foot Infections
Interventions: Procedure: Surgical incision and drainage of diabetic foot infection;   Drug: Short course antibiotics;   Drug: Long course antibiotics
38 Terminated The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcers
Interventions: Device: Unite Biomatrix;   Other: Saline and Gauze
39 Not yet recruiting Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)
Conditions: Microalbuminuria;   Endothelial Dysfunction;   Diabetic Nephropathy;   Diabetic Retinopathy
Intervention: Other: non intervention
40 Recruiting Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Drug: DSC127;   Drug: placebo vehicle gel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years